benperidol has been researched along with Dyskinesia, Drug-Induced in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seeman, P; Tallerico, T | 1 |
Connemann, BJ; Juengling, FD; Kassubek, J; Reske, SN; Schönfeldt-Lecuona, C; Spitzer, M | 1 |
Eben, E; Klein, H; Krüger, R; Nedopil, N; Rüther, E; Schmauss, M | 1 |
1 review(s) available for benperidol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Topics: Antipsychotic Agents; Binding, Competitive; Cholinergic Antagonists; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Resistance; Dyskinesia, Drug-Induced; Humans; Levodopa; Ligands; Limbic System; Nerve Tissue Proteins; Parkinson Disease, Secondary; Protein Binding; Psychoses, Substance-Induced; Psychotic Disorders; Radioligand Assay; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Serotonin; Recurrence; Serotonin Antagonists; Tomography, Emission-Computed | 1998 |
1 trial(s) available for benperidol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
High-dosage neuroleptic therapy for acute schizophrenic patients--two double-blind studies with benperidol.
Topics: Benperidol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1985 |
1 other study(ies) available for benperidol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.
Topics: Adult; Basal Ganglia; Benperidol; Carbon Radioisotopes; Clozapine; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Fluorine Radioisotopes; Humans; Male; Raclopride; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome; Ultrasonography | 2004 |